US › Healthcare

NuCana PLC (NCNA)

US · Healthcare · Biotechnology

$1.39+2.96%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$-3.9M
Profit YoY
-56.3%
EPS
$-0.08
EPS estimate
$-13.00

EPS came in at -0.08 against a street estimate of -13.00 — a beat of 99.4%.

Key statistics

Market cap
$5.5M
P/E
0.0
Forward P/E
0.0
P/B
0.19
Book value
$7.14
EPS (TTM)
$134.60
52-week high
$10.00
52-week low
$1.21
50-day MA
$1.66
200-day MA
$2.58
Beta
2.22

Analyst view

Analysts rate NuCana PLC a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $104.00.

Shareholding

Insiders
0.00%
Institutions
1.38%

Largest institutional holders

FundStake
Glass Jacobson Investment Advisors LLC0.36%
Citadel Advisors Llc0.33%
Virtu Financial LLC0.32%
Jane Street Group LLC0.25%
Rhumbline Advisers0.09%
Morgan Stanley - Brokerage Accounts0.00%
Acadian Asset Management LLC0.00%
Caitong International Asset Management Co., Limited.0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for NuCana PLC — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.